Results 21 to 30 of about 29,409 (232)
Correction: Serum sickness-like reaction to D-Supplement: A Case Report [PDF]
BMC PediatricsEmma R. Plante +3 more
doaj +2 more sources
Serum Sickness-Like Reaction Associated with Epstein – Barr Virus: Clinical Case
Вопросы современной педиатрии, 2022 Background. Annular dermatoses are a group of diseases with major clinical manifestation of rashes of relevant form. This manifestation pattern causes difficulties in diagnosis.
Vladislav V. Ivanchikov +3 more
doaj +1 more source
Pathophysiology and clinical manifestations of immune complex vasculitides
Frontiers in Medicine, 2023 Immune complex (IC) vasculitides present inflammations of vessel walls associated with perivascular deposition of immunoglobulins (Igs), mostly ICs. They encompass systemic and skin-limited variants of IgA vasculitis (IgAV), cryoglobulinemic vasculitis ...
Cord Sunderkötter +3 more
doaj +1 more source
Serum-Sickness in Rabbits [PDF]
The Journal of Immunology, 1931 Abstract The studies here reported relate primarily to the rôle that the lipids play in the causation of serum-sickness in rabbits. The word lipid is used as an inclusive term embracing all those substances removed from serum by commonly employed solvents such as alcohol, ether and similar materials.
Moyer S Fleisher, Lloyd R Jones
openaire +2 more sources
Frontiers in Allergy, 2023 Several monoclonal antibodies have been approved by the Food and Drug Administration (FDA) to treat allergic disorders, including omalizumab, dupilumab, mepolizumab, reslizumab, benralizumab, tralokinumab and tezepelumab, and their indications continue ...
Andrea Sitek +2 more
doaj +1 more source
Rituximab-induced serum sickness and anaphylaxis in a child with nephrotic syndrome
The Turkish Journal of Pediatrics, 2020 Background. Rituximab is effective for treatment of children with refractory nephrotic syndrome (NS). However, the drug may cause serum sickness characterized by fever, rash, and arthralgia 10-14 days after primary antigen exposure or within a few
Meral Torun Bayram +2 more
doaj +1 more source
Reacción similar a la enfermedad del suero secundaria al uso de cefalotina: reporte de un caso
Infectio, 2022 Serum sickness (SS) and SS-like reactions (SSLR) are indistinguishable clinical entities but with different pathophysiological processes, particularly regarding its impact on the complement system.
Germán Sepúlveda-Barbosa
doaj +1 more source
Rituximab Hypersensitivity: From Clinical Presentation to Management
Frontiers in Pharmacology, 2020 Rituximab is a chimeric monoclonal antibody (mAb) against CD20 molecule which is expressed on human B cells. It has been used for the treatment of various lymphoid malignancies, lymphoproliferative diseases, and rheumatologic disorders.
Ghada E. Fouda, Sevim Bavbek
doaj +1 more source
Lipopolysaccharide‐induced sickness behavior is not altered in male Fmr1‐deficient mice
Brain and Behavior, 2023 Objectives Fragile X syndrome is the main monogenetic cause of intellectual disability and autism. Alterations in the immune system are commonly found in these developmental disorders.
Danielle Santana‐Coelho +8 more
doaj +1 more source
Life‐Threatening Bradycardia in Anti‐NMDA‐Receptor Encephalitis and a Novel Use for Permanent Pacing
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Pediatric anti‐NMDA receptor encephalitis (pNMDARE) is an autoantibody‐mediated disorder that can cause severe autonomic dysfunction, including symptomatic bradycardia and asystole. Dysautonomia can last for years, making it very challenging to manage.
Sarah Tucker +9 more
wiley +1 more source